Biff #SARSisAirborne 🍉
@Biff234523 • 3,640 subscribers
He/Him. Malarkey destroyer.
Videos
🚨💉Technically, this is Novavax distribution news. Novavax had a panel at the Cantor Global Healthcare Conference this morning, and they gave us an explanation (in their own words, noting that they can’t speak for Sanofi) for why distribution has been so lackluster this year. Essentially, the bulk of the contracting happens prior to May, and Nuvaxovid had not yet received BLA approval or their 6 month shelf life extension at that time, therefore Sanofi was either unable or unwilling to do proper contracting. I don’t like that one bit, but it’s an explanation. That said, it’s just as unacceptable to me and goes back to exactly what I said in my original tweet. Sanofi absolutely doesn’t “get it” if they feel that they can phone it in as a “learning year” right now. They’re not showing signs of being very appreciative of the base that we’ve given them here, which should’ve been a very easy thing to take advantage of if they weren’t so risk averse. And they completely lack understanding of the market they’re in if they fail to understand that Nuvaxovid both has a large “fanbase” and is the most maligned vaccine in recent history, therefore any significant delay will continue to cost them a large portion of market share. While enlightening, and a little upsetting, it doesn’t fundamentally change anything with what we need to do here. Obviously the contact and education campaign needs to continue. Contact both Sanofi and Novavax to explain what Nuvaxovid access means to you and express your desire for a proper distribution immediately. And then contact your pharmacies to encourage them to stock Nuvaxovid when it becomes available for order. As always, be polite when calling and never be rude. Sanofi: 1-800-981-2491 Novavax: 1-844-668-2829
Biff #SARSisAirborne 🍉22,879 views • 9 months ago
No more content to load